4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050148
CEO acquired 57,612 shares (option exercise)
- CEO gave up 17,230 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise | +36,008 | $3.70 | $133,230 | 264,143 | D |
| PIMSTONE SIMON N. CEO | 2019-09-17 | Shares withheld for taxes | −10,769 | $9.44 | $101,659 | 253,374 | D |
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise | +9,259 | $3.07 | $28,425 | 262,633 | D |
| PIMSTONE SIMON N. CEO | 2019-09-17 | Shares withheld for taxes | −2,769 | $9.44 | $26,139 | 259,864 | D |
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise | +12,345 | $3.38 | $41,726 | 272,209 | D |
| PIMSTONE SIMON N. CEO | 2019-09-17 | Shares withheld for taxes | −3,692 | $9.44 | $34,852 | 268,517 | D |
| Derivatives | |||||||
| PIMSTONE SIMON N. CEO | 2019-09-16 | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | D | ||
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise · Stock Option (Right to Buy) | −36,008 | 0 | D | ||
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise · Stock Option (Right to Buy) | −9,259 | 0 | D | ||
| PIMSTONE SIMON N. CEO | 2019-09-17 | Option exercise · Stock Option (Right to Buy) | −12,345 | 0 | D | ||
Loading xslF345X03/doc4.xml…